title: Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection.
authors.forename: Willem Joost
authors.initials: WJ
authors.lastname: Wiersinga
authors.forename: Jan M
authors.initials: JM
authors.lastname: Prins
authors.forename: Diederik
authors.initials: D
authors.lastname: van de Beek
mesh_terms: D000328:Adult; D000588:Amines / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D005260:Female; D000077206:Gabapentin; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D015497:HIV-1; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D053578:Opsoclonus-Myoclonus Syndrome / Q000209:etiology*; D011239:Prednisolone / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D017211:Treatment Failure; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D019380:Anti-HIV Agents; D000893:Anti-Inflammatory Agents; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D016756:Immunoglobulins, Intravenous; D012367:RNA, Viral; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D011239:Prednisolone